$2.61 0.13 (+5.24%)
11/6/2009 4:00 PM

Aryx Therapeutics (ARYX)

CAPS Rating: 5 out of 5

Current Price $2.61 Mkt Cap $71.64M
Open $2.45 P/E Ratio 0.41
Prev. Close $2.48 Div. (Yield) N/A (N/A)
Daily Range $2.45 - $2.62 Volume 44,907
52-Wk Range $1.10 - $6.32 Avg. Daily Vol. 66,000

ARYX News and Commentary

Related News and Articles

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

53 Outperform
3 Underperform
 

All-Star Members

30 Outperform
2 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top ARYX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.36)
Submitted May 27, 2009

This pick represents something of an improvement over my entry price of 8 a year and a half ago. Since that time pipeline developments have been generally positive, despite the share price dwindling as low as 1.5 in the darkest hours of small cap… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ARYX VS S&P 500 (SPY)

Fools bearish on ARYX are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about ARYX.

Recs

0
Member Avatar ResearchLover (74.95) Submitted: 8/21/2009 8:29:29 PM : Outperform Start Price: $3.66 ARYX Score: -32.80

1) zzlh's insight on the pipeline

2) 14 day RSI creeping above 50 just now

3) Insider confidence in purchases late in 08

4) general consensus.

Recs

0
Member Avatar JakilaTheHunII (55.72) Submitted: 8/7/2009 8:41:40 AM : Outperform Start Price: $3.72 ARYX Score: -36.59

About a month ago, I made the declaration that I will not make any more biotech red thumb picks. The problem is that the very nature of the sector lends itself to constant speculation and smooth-talking companies with no real prospects can sweet talk investors for years before the market finally realizes they are worthless.

So now I'm convinced that the only way to make money in biotech is playing things on the long end. Only problem is that picking the winners is much more difficult than picking the losers. Also, consider the fact that I have no medical background and I am obviously not the best judge of these things.

I like what I've read about ARYX and believe they have some positive catalysts. The zzlangerhans green thumb pitch has also helped sway me. I have no confidence in my ability to pick biotech stocks, though, so take everything I say with a grain of salt.

Recs

0
Member Avatar anshulinpc (< 20) Submitted: 7/3/2009 8:30:08 PM : Outperform Start Price: $4.57 ARYX Score: -63.92

testing results will be positive.

Leaderboard

Find the members with the highest scoring picks in ARYX.

Score Leader

HDTVBG

HDTVBG (69.26) Score: +95.14

Conference call coming 11-12 @ 8 AM. Morning calls are good news, bad stuff is released after hours. Announcing a licensing deal? Can't thumb-up again until $3.66 . Good luck to all . . .

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
PauvrePapillon 99.59 11/8/2007 Underperform 1Y $8.30 -68.55% -24.16% +44.40
surfNH 86.36 1/2/2008 Underperform 1Y $7.96 -67.21% -23.81% +43.40
BehindBlueEyes < 20 8/5/2009 Underperform NS $3.81 -31.50% +6.82% +38.32
intersub 98.04 8/24/2009 Outperform 5Y $3.55 -26.48% +4.32% -30.80
ResearchLover 74.95 8/24/2009 Outperform 3M $3.66 -28.69% +4.11% -32.80 1 Comment
pennysplants 99.37 9/19/2008 Outperform 1Y $4.81 -45.74% -11.80% -33.94
JakilaTheHunII 55.72 8/7/2009 Outperform 5Y $3.72 -29.84% +6.75% -36.59 1 Comment
expatriot08 84.42 8/21/2009 Outperform 3M $3.85 -32.21% +5.72% -37.93
bige6565 < 20 12/3/2007 Outperform 5Y $7.50 -65.20% -24.26% -40.94 1 Comment
DiversifyKing 82.93 11/9/2007 Outperform 5Y $7.44 -64.92% -23.07% -41.84

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWedbush < 20 7/2/2009 Outperform NS $4.52 -42.26% +19.08% -61.33
TrackHapoalim 51.20 4/30/2009 Outperform NS $4.00 -34.75% +22.24% -56.99
TrackJefferies 75.83 1/15/2008 Outperform NS $9.47 -72.44% -20.13% -52.31
TrackLeerinkSwan 84.26 12/18/2007 Outperform NS $8.10 -67.78% -23.07% -44.71

Featured Broker Partners